Range Low Price High Price Comment
30 days $133.39 $156.84 Wednesday, 1st May 2024 ASND stock ended at $141.01. This is 1.86% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.82% from a day low at $136.00 to a day high of $142.55.
90 days $129.25 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Aug 18, 2023 $87.14 $91.55 $86.94 $90.47 169 991
Aug 17, 2023 $89.98 $90.95 $86.83 $87.92 231 077
Aug 16, 2023 $92.50 $92.57 $89.80 $89.90 182 335
Aug 15, 2023 $92.50 $95.00 $91.21 $92.50 418 775
Aug 14, 2023 $92.35 $92.88 $88.52 $92.21 156 985
Aug 11, 2023 $90.53 $93.00 $90.50 $92.30 115 096
Aug 10, 2023 $94.98 $95.44 $90.38 $90.53 289 068
Aug 09, 2023 $94.64 $96.76 $92.69 $94.94 394 746
Aug 08, 2023 $91.78 $96.75 $91.51 $94.09 308 278
Aug 07, 2023 $96.82 $97.00 $91.55 $91.70 282 617
Aug 04, 2023 $94.43 $97.24 $94.16 $96.79 305 885
Aug 03, 2023 $91.55 $95.82 $90.77 $94.32 288 644
Aug 02, 2023 $91.10 $92.49 $89.76 $91.29 199 786
Aug 01, 2023 $90.05 $91.66 $88.87 $91.62 277 207
Jul 31, 2023 $93.20 $93.20 $90.00 $90.15 233 414
Jul 28, 2023 $88.31 $94.68 $87.74 $93.10 422 892
Jul 27, 2023 $86.81 $87.94 $85.76 $87.55 279 468
Jul 26, 2023 $86.86 $87.02 $85.32 $86.67 205 609
Jul 25, 2023 $86.45 $88.66 $86.45 $87.25 286 946
Jul 24, 2023 $89.25 $89.25 $85.64 $86.50 290 700
Jul 21, 2023 $90.28 $90.74 $87.97 $89.25 232 180
Jul 20, 2023 $90.59 $91.24 $88.66 $90.06 263 239
Jul 19, 2023 $89.46 $91.10 $89.06 $90.54 233 271
Jul 18, 2023 $87.36 $89.13 $87.07 $89.00 187 949
Jul 17, 2023 $87.08 $88.68 $86.22 $87.20 206 191
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT